Inostamycin prevents malignant phenotype of cancer: inhibition of phosphatidylinositol synthesis provides a therapeutic advantage for head and neck squamous cell carcinoma.
about
Inostamycin prevents malignant phenotype of cancer: inhibition of phosphatidylinositol synthesis provides a therapeutic advantage for head and neck squamous cell carcinoma.
description
article científic
@ca
article scientifique
@fr
articolo scientifico
@it
artigo científico
@pt
bilimsel makale
@tr
scientific article published on February 2010
@en
vedecký článok
@sk
vetenskaplig artikel
@sv
videnskabelig artikel
@da
vědecký článek
@cs
name
Inostamycin prevents malignant ...... neck squamous cell carcinoma.
@en
Inostamycin prevents malignant ...... neck squamous cell carcinoma.
@nl
type
label
Inostamycin prevents malignant ...... neck squamous cell carcinoma.
@en
Inostamycin prevents malignant ...... neck squamous cell carcinoma.
@nl
prefLabel
Inostamycin prevents malignant ...... neck squamous cell carcinoma.
@en
Inostamycin prevents malignant ...... neck squamous cell carcinoma.
@nl
P2093
P2860
P356
P1476
Inostamycin prevents malignant ...... neck squamous cell carcinoma.
@en
P2093
Kaoru Ogawa
Yasumasa Kato
P2860
P304
P356
10.1042/CBI20090310
P577
2010-02-01T00:00:00Z